期刊文献+

抗甲状腺功能亢进症药物引起的以肺肾综合征为表现的ANCA相关性血管炎的临诊应对 被引量:8

Approach to the patient with pulmonary-renal syndrome caused by antithyroid drug-induced ANCA-associated vasculitis
原文传递
导出
摘要 药物引起的ANCA相关性血管炎(antineutrophil aytoplasmic antibody—associated vasculitis,AAV)是一组具有潜在危及生命的自身免疫性疾病,抗甲亢药物是其中常见的病因之一。临床上常见累及皮肤,肾脏和(或)肺部。早期诊断和治疗至关重要,及时停用抗甲亢药物,或使用糖皮质类同醇和(或)免疫抑制剂等能延缓或阻止病情进展。 Antineutrophil cy[oplasmie antibody-associated vasculitis ( AAV ) refers to the groups of potentially life-threatening autoimmune disease. Antithyroid drug is one of the causes. Usually the involved organs are skin, kidney, and(or) lung. Early diagnosis and treatment of AAV is essential. Timely cessation of antithyroid drugs is the first step. If necessary, glucocorticoids and (or) immunosuppressive agents should be used to delay the progression of the disease.
出处 《中华内分泌代谢杂志》 CAS CSCD 北大核心 2014年第2期171-173,共3页 Chinese Journal of Endocrinology and Metabolism
关键词 抗甲状腺功能亢进症药物 ANCA相关性血管炎 肺一肾综合征 Antithyroid drugs Antineutrophil cytoplasmic antibody-associated vasculitis Pulmonary-renalsyndrome
  • 相关文献

参考文献24

  • 1Stankus SJ,Johnson NT. Propylthiouracil-induced hypersensitivity vasculitis presenting as respiratory failure[J].CHEST,1992.1595-1596.
  • 2Dolman KM,Gans RO,Vervaat TJ. Vasculitis and antineutrophil cytoplasmic autoantibodies associated with propylthiouracil therapy[J].LANCET,1993.651-652.
  • 3Chen M,Gao Y,Guo XH. Propylthiouracil-induced antineutrophil cytoplasmic antibody-associated vasculitis[J].Nat Rev Nephrol,2012.476-483.
  • 4Noh JY,Yasuda S,Sato S. Clinical characteristics of myeloperoxidase antineutrophil cytoplasmic antibody-associated vasculitis caused by antithyroid drugs[J].Journal of Clinical Endocrinology and Metabolism,2009.2806-2811.
  • 5Gao Y,Zhao MH,Guo XH. The prevalence and target antigens of anti thyroid drugs induced antineutrophil cytoplasmic antibodies (ANCA) in Chinese patients with hyperthyroidism[J].Endocr Res,2004.205-213.
  • 6Kawachi Y,Nukaga H,Hoshino M. ANCA-associated vasculitis and lupus-like syndrome caused by methimazole[J].CLINICAL AND EXPERIMENTAL DERMATOLOGY,1995.345-347.
  • 7Lee E,Hirouchi M,Hosokawa M. Inactivation of peroxidases of rat bone marrow by repeated administration of propylthiouracil is accompanied by a change in the heme structure[J].Biochemical Pharmacology,1988.2151-2153.
  • 8von Schmiedeberg S,Goebel C,Gleichmann E. Neutrophils and drug metabolism[J].SCIENCE,1995.585-586.
  • 9Zhang AH,Chen M,Gao Y. Inhibition of oxidation activity of myeloperoxidase (MPO) by propylthiouracil (PTU) and anti-MPO antibodies from patients with PTU-induced vasculitis[J].CLINICAL IMMUNOLOGY,2007.187-193.
  • 10Stankus SJ,Johnson NT. Propylthiouracil-induced hypersensitivity vasculitis presenting as respiratory failure[J].CHEST,1992.1595-1596.

二级参考文献20

  • 1叶华,高莹,郭晓蕙,赵明辉.丙基硫氧嘧啶诱发的抗中性粒细胞胞质抗体阳性甲状腺功能亢进患者的临床研究[J].中华医学杂志,2005,85(47):3323-3327. 被引量:19
  • 2Gao Y,Zhao MH,Guo XH,et al.The prevalence and target antigens of anti-thyroid drugs induced antineutrophil cytoplasmic antibodies (ANCA) in Chinese patients with hyperthyroidism.Endocr.Res,2004,30:205-213.
  • 3Slot MC,Links TP,Stegeman CA,et al.Occurrence of antineutrophil cytoplasmic antibodies and associated vasculitis in patients with hyperthyroidism treated with anti-thyroid drugs:A long-term follow-up study.Arthritis Rheum,2005,53:108-113.
  • 4Choi HK,Merkel PA,Walker AM,Niles JL.Drug-associated antineutrophil cytoplasmic antibody-positive vasculitis:prevalence among patients with high titers of antimyeloperoxidase antibodies.Arthritis Rheum,2000,43:405 -413.
  • 5Fujieda M,Hattori M,Kurayama H,et al.Clinical features and outcomes in children with antineutrophil cytoplasmic autoantibodypositive glomerulonephritis associated with propylthiouracil treatment.J Am Soc Nephrol,2002,13:437 -445.
  • 6Noh JY,Yasuda S,Sato S,et al.Clinical Characteristics of myeloperoxidase antineutrophil cytoplasmic antibody-associated vasculitis caused by antithyroid drugs.J Clin Endocrinol Metab,2009,94:2806 -2811.
  • 7Yu F,Chen M,Gao Y,et al.Clinical and pathological features of renal involvement in propylthiouracil-associated ANCA-positive vasculitis.Am J Kidney Dis,2007,49:607-614.
  • 8Noh JY,Asari T,Hamada N,et al.Frequency of appearance of myeloperoxidase-antineutrophil cytop lasmic antibody (MPO-ANCA)in Graves' disease patients treated with propylthiouracil and the relationship between MPO-ANCA and clinical manifestations.Clin Endocrinol (Oxf),2001,54:651-654.
  • 9Zhao MH,Chen M,Gao Y,et al.Propylthiouracil-induced anti-neutrophil cytoplasmic antibody-associated vasculitis.Kidney Int,2006,69:1477-1481.
  • 10Fujieda M,Suzuki K,Sato H,et al.Epitope analysis of myeloperoxidase-specific antineutrophil cytoplasmic autoantibodies(MPO-ANCA)in childhood onset Graves'disease treated with propylthiouracil.Clin Nephrol,2005,63:437-445.

共引文献10

同被引文献75

引证文献8

二级引证文献47

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部